Unprecedented numbers of technical papers, abstracts, and short commun
ications have been published in the past decade regarding the effects
of exogenous bovine growth hormone on milk production, health, and rep
roductive efficiency of treated dairy cows. In well-managed dairy herd
s, exogenous growth hormone increases milk production without altering
normal variability in milk composition. This has held true regardless
of dairy breed tested, geographical location studied, or feeding mana
gement system used. Also consistent across studies is the rapidity of
the galactopoietic effect of administered bovine growth hormone, which
arises from altered partitioning and use of post-absorptive nutrients
and increased synthetic capacity of the mammary gland. Growth hormone
and its associated peptide, insulin-like growth factor-1, are now kno
wn to provide chronic lipolytic, diabetogenic, and gluconeogenic signa
ls to target tissues culminating in increased mammary gland availabili
ty of glucose and nonesterified fatty acids. Together with yet ill-def
ined effects on mammary secretory tissue, this homeorhetic control of
metabolism elicited by exogenous growth hormone is so efficient that t
reated cows are not more susceptible to metabolic disorders than untre
ated cows. However, some studies have reported an increased frequency
of mastitis in groups of treated cows. This has been attributed mainly
to increased milk volume in the mammary glands of treated cows and no
convincing data are available that show decreased mammary gland immun
ity as a result of growth hormone treatments. On the contrary, an expa
nding body of evidence implicates growth hormone as a key neuroendocri
ne factor that is required for immunological competence. Trends of dec
reased reproductive efficiency in cows treated with growth hormone hav
e also been reported, but available data imply that this is probably a
n indirect effect via prolonged negative energy balance in cows treate
d in early lactation rather than a direct negative effect on estrous c
ycling via altered reproductive hormone profiles. The objectives of th
e present review are to bring into focus and summarize pertinent biolo
gical discoveries regarding the treatment of dairy cows with recombina
nt bovine growth hormone, and to explore areas where additional growth
hormone research is needed or warranted.